10th Annual InWomen’s Conference

The 10th annual conference on new and significant findings about the consequences of substance use, abuse, and risk behaviors, hosted by the International Women’s and Children’s Health and Gender Group. The group aims to identify and promote innovative research that helps to empower women across the lifespan, foster gender-based analyses in research, and promote the benefits of prevention, intervention, and treatment.

Abstracts are now being accepted!

Abstracts with a focus or component on women, children, youth, LGBT+ individuals, and/or gender differences in areas pertaining to substance use will be considered.

Submission Deadline: January 06, 2017 at 11:59 PM EST
Abstract and Travel Award Notifications will be sent by: February 24, 2017
Visa Letters Issued: February 24 – March 24, 2017

Click here for the Abstract Submission Form.

Women and HIV Cure: Barriers and Facilitators to Women’s Participation in Cure Research

A Three-Part Webinar Series Presented by the Women’s HIV Research Collaborative (Part 3)

Thursday, November 17

In recent years, the scientific community has made great strides toward finding a cure for HIV. Activists and advocates are rightfully excited about these developments, but many questions remain about what a cure will entail and how the science might reach different populations and communities. While cure research has generated exciting results, it is crucial that these results include and are relevant to all people with HIV. Women, however, are often excluded or otherwise left out of HIV cure efforts. The members of the Women’s HIV Research Collaborative (WHRC) believe that cure research must include women—cisgender and transgender alike—in order to produce results that are applicable and meaningful to women. In this spirit of sisterhood and the meaningful involvement of people with HIV, the WHRC has assembled a diverse group of expert women working in community advocacy, biomedical research, and bioethics to guide us through this three-part webinar series.

Women and HIV Cure: What Cure Means to Women, What Women Mean to Cure

A Three-Part Webinar Series Presented by the Women’s HIV Research Collaborative (Part 2)

Tuesday, October 25

In recent years, the scientific community has made great strides toward finding a cure for HIV. Activists and advocates are rightfully excited about these developments, but many questions remain about what a cure will entail and how the science might reach different populations and communities. While cure research has generated exciting results, it is crucial that these results include and are relevant to all people with HIV. Women, however, are often excluded or otherwise left out of HIV cure efforts. The members of the Women’s HIV Research Collaborative (WHRC) believe that cure research must include women—cisgender and transgender alike—in order to produce results that are applicable and meaningful to women. In this spirit of sisterhood and the meaningful involvement of people with HIV, the WHRC has assembled a diverse group of expert women working in community advocacy, biomedical research, and bioethics to guide us through this three-part webinar series.

FHI 360/UNC CFAR Brown Bag Lunch

Come join us for the first Brown Bag Lunch gathering of FHI 360 and UNC CFAR researchers and investigators.

Agenda:
11:30-11:45 – Introduction – Ron Swanstrom
11:45-12:00 – Developmental Core – Kate MacQueen
12:00-12:15 – STI Testing Capacity – Marcia Hobbs
12:15-12:30 – Women’s Reproductive Health – Jeff Stringer
12:30-12:45 – Social and Behavioral Instrument Database – Carol Golin
12:45-1:00 – Statistical consulting services – Katie Mollan & Cam Bay

The event will be held in Room 2104, the main conference room at FHI 360. The building is located at 359 Blackwell St. Ste 200, right next to the Durham Bulls ballpark.

Lunch will be provided!

Parking information can be found here.

CALL FOR ABSTRACTS: 2016 Inter-CFAR Collaboration on HIV Research in Women Symposium

Women%20and%20HIV%20Logo%202016%20

Deadline for Abstract Submission: Sunday, October 2, 2016

Conference: December 6 & 7, 2016

Birmingham, AB

The CFAR Joint Symposium on HIV Research in Women is soliciting abstracts for posters and oral presentations from investigators at CFAR-affiliated institutions in each of the below three areas:

  • Vulnerable Populations
  • Microbiome in HIV-Infected Women and its Impact on Health Outcomes
  • The HIV Continuum of Care Across the Lifespan of Women

Priority given to junior and mid-level investigators from doctoral students through assistant professor titles.  Abstracts must be no more than 350 words in length.  Review criteria include overall impact, contribution to the field of HIV in women, and relevance to one or more of the three session topics. Some travel support will be available based on need. There will be no registration fee for this symposium.

The goal of the CFAR Joint Symposium on HIV Research in Women is to identify gaps in knowledge in HIV and women’s research and develop strategies that will move the field forward.

Click here to submit abstracts.

Click here to learn more about the symposium.

Please email Julia Dettinger with questions regarding abstract submission.

UNC bioethicist addresses lack of HIV studies in pregnant women

UNC School of Medicine’s Anne Lyerly is addressing the urgent need for effective HIV prevention and treatment for the estimated 1.5 million women worldwide with HIV who give birth each year. With a $3 million NIH grant, Dr. Lyerly is leading an interdisciplinary team of researchers to determine what barriers prevent investigators from studying the virus in pregnant women.

Lyerly, associate director of the UNC Center for Bioethics and associate professor of social medicine at the UNC School of Medicine, is also an obstetrician/gynecologist who studies ethically complex clinical and policy issues related to women’s reproductive health.

In the August issue of the Journal of the International AIDS Society, Lyerly addresses the lack of research of HIV-positive pregnant women and pregnant women who are at risk of contracting HIV, which has “led to a dearth of evidence to guide safe and effective treatment and prevention of HIV in pregnancy,” Lyerly wrote.

In the research on the HIV-positive pregnant women that has been done, most outcomes focus entirely on the health of the fetus. Pregnant women are excluded from the vast majority of studies, including studies on how to best prevent HIV.

Read more here…

5th International Workshop on HIV & Women

HIV & Women5th International Workshop on HIV & Women, from Adolescence through Menopause

February 21 – 22, 2015
Seattle, WA

This international workshop provides a unique platform for experts involved in research and treatment of HIV-infected women to present and discuss the latest developments in the field and identification of treatment strategies for the future. The workshop provides an interactive scientific program consisting of overview talks by key opinion leaders, oral abstract presentations, Q&A sessions, poster sessions, roundtable- and patient case discussions.

Abstract submissions for a poster or oral presentation are open through December 5, 2014. Accepted abstracts will be published in the journal Reviews in Antiviral Therapy & Infectious Diseases.

Download the event flyer here.